SPRINGWORKS THERAPEUTICS INC's ticker is SWTX and the CUSIP is 85205L107. A total of 138 filers reported holding SPRINGWORKS THERAPEUTICS INC in Q1 2021. The put-call ratio across all filers is - and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2022 | $782,000 | -9.0% | 13,855 | -0.0% | 0.00% | 0.0% |
| Q4 2021 | $859,000 | -7.3% | 13,859 | -5.2% | 0.00% | -25.0% |
| Q3 2021 | $927,000 | -22.8% | 14,615 | +0.4% | 0.00% | -33.3% |
| Q2 2021 | $1,200,000 | +34.2% | 14,556 | +19.8% | 0.01% | +20.0% |
| Q1 2021 | $894,000 | – | 12,152 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Bain Capital Life Sciences Investors, LLC | 4,831,307 | $272,679,000 | 26.48% |
| Boxer Capital, LLC | 2,075,905 | $117,164,000 | 6.02% |
| Orbimed Advisors | 6,028,307 | $340,238,000 | 5.52% |
| Perceptive Advisors | 4,527,993 | $255,560,000 | 5.12% |
| SPHERA FUNDS MANAGEMENT LTD. | 460,025 | $25,964,000 | 3.67% |
| Affinity Asset Advisors, LLC | 247,000 | $13,941,000 | 2.23% |
| Artal Group S.A. | 850,000 | $47,974,000 | 2.01% |
| Affinity Asset Advisors, LLC | 160,000 | $9,030,000 | 1.44% |
| DRIEHAUS CAPITAL MANAGEMENT LLC | 1,841,799 | $103,951,000 | 1.28% |
| SPHERA FUNDS MANAGEMENT LTD. | 125,000 | $7,055,000 | 1.00% |